Serina Therapeutics's total assets for Q1 2025 were $6.73M, an increase of 0.10% from the previous quarter. SER total liabilities were $5.17M for the fiscal quarter, a -16.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.